Breaking News, Promotions & Moves

Iterative Health Adds Nadege Gunn as CMO, Hepatology and Obesity

Gunn will provide medical and scientific leadership across metabolic liver disease research and specialized site operations.

Author Image

By: Patrick Lavery

Content Marketing Editor

Iterative Health has hired Nadege Gunn, MD, as Chief Medical Officer (CMO), Hepatology and Obesity. Gunn currently practices at Texas-based Coryell Health, serving there as hepatology clinic director. She is the founder, and former president and CEO, of the hepatology-focused Impact Research Institute in Waco, Texas. Role of New CMO Gunn’s appointment to the Iterative Health team serves to provide strategic medical and scientific leadership in metabolic liver disease research. Gunn will al...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters